MUNICH, Germany – Aigora and the Department of Dermatology at University Medical Center Mainz have published a study in the Journal of the American Academy of Dermatology on how artificial intelligence and physicians can work together to diagnose melanoma. The study was co-authored by Aigora’s founders, Christian Ludwigs and Dominik Seliger.
Previous studies have often compared AI and physicians head-to-head. This study looked instead at how AI support affects physicians’ own decisions. In two sessions held more than four months apart, 64 physicians assessed a deliberately challenging set of 100 dermoscopic images, half melanomas and half benign nevi. In the first session they assessed the images alone. In the second, they were supported by an AI-based traffic light system developed by Aigora and trained on more than 28,000 dermoscopic images.
With AI support, the physicians detected melanomas more reliably and also classified benign lesions more accurately. This held across all physician groups, with general practitioners benefiting most. The authors conclude that AI can add value in challenging cases and that further studies in real-world settings are needed.
Read the publication in the Journal of the American Academy of Dermatology
About Aigora
Aigora is a real-world data partner for life sciences and medtech companies. Through its network of healthcare partner sites across Europe and beyond, Aigora discovers, sources, curates and delivers multimodal, regulatory-grade datasets tailored to specific research and development needs.